Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 38226814)

  • 1. The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.
    Khalil MI; Yang C; Vu L; Chadha S; Nabors H; James CD; Morgan IM; Pyeon D
    J Virol; 2024 Feb; 98(2):e0172623. PubMed ID: 38226814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.
    Khalil MI; Yang C; Vu L; Chadha S; Nabors H; James CD; Morgan IM; Pyeon D
    bioRxiv; 2023 Nov; ():. PubMed ID: 37961092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV upregulates MARCHF8 ubiquitin ligase and inhibits apoptosis by degrading the death receptors in head and neck cancer.
    Khalil MI; Yang C; Vu L; Chadha S; Nabors H; Welbon C; James CD; Morgan IM; Spanos WC; Pyeon D
    PLoS Pathog; 2023 Mar; 19(3):e1011171. PubMed ID: 36867660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase.
    Oh KJ; Kalinina A; Wang J; Nakayama K; Nakayama KI; Bagchi S
    J Virol; 2004 May; 78(10):5338-46. PubMed ID: 15113913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
    Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
    FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor.
    Huh K; Zhou X; Hayakawa H; Cho JY; Libermann TA; Jin J; Harper JW; Munger K
    J Virol; 2007 Sep; 81(18):9737-47. PubMed ID: 17609271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation.
    Westrich JA; Warren CJ; Klausner MJ; Guo K; Liu CW; Santiago ML; Pyeon D
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29367246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.
    Hatterschide J; Brantly AC; Grace M; Munger K; White EA
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of HPV E7 Stability by E6-Associated Protein (E6AP).
    Vats A; Trejo-Cerro O; Massimi P; Banks L
    J Virol; 2022 Aug; 96(16):e0066322. PubMed ID: 35916535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells.
    Rampias T; Boutati E; Pectasides E; Sasaki C; Kountourakis P; Weinberger P; Psyrri A
    Mol Cancer Res; 2010 Mar; 8(3):433-43. PubMed ID: 20215420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZER1 Contributes to the Carcinogenic Activity of High-Risk HPV E7 Proteins.
    Nouel J; White EA
    mBio; 2022 Dec; 13(6):e0203322. PubMed ID: 36346242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression of Memo1, a Novel Target of Human Papillomavirus Type 16 E7, Increases Cell Proliferation in Cervical Cancer Cells.
    Trejo-Cerro O; Massimi P; Broniarczyk J; Myers M; Banks L
    J Virol; 2022 Oct; 96(20):e0122922. PubMed ID: 36197110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response.
    Sitz J; Blanchet SA; Gameiro SF; Biquand E; Morgan TM; Galloy M; Dessapt J; Lavoie EG; Blondeau A; Smith BC; Mymryk JS; Moody CA; Fradet-Turcotte A
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19552-19562. PubMed ID: 31501315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest.
    Li C; Johnson DE
    Cell Cycle; 2013 Mar; 12(6):923-34. PubMed ID: 23421999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Analysis of IL-1 Cytokine Signaling Suppression by HPV16 Oncoproteins.
    Castagnino P; Kim HW; Lam LKM; Basu D; White EA
    J Virol; 2022 Nov; 96(22):e0132622. PubMed ID: 36342298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.
    Chiang C; Pauli EK; Biryukov J; Feister KF; Meng M; White EA; Münger K; Howley PM; Meyers C; Gack MU
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53.
    Niebler M; Qian X; Höfler D; Kogosov V; Kaewprag J; Kaufmann AM; Ly R; Böhmer G; Zawatzky R; Rösl F; Rincon-Orozco B
    PLoS Pathog; 2013; 9(8):e1003536. PubMed ID: 23935506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotavirus NSP1 Associates with Components of the Cullin RING Ligase Family of E3 Ubiquitin Ligases.
    Lutz LM; Pace CR; Arnold MM
    J Virol; 2016 Jul; 90(13):6036-48. PubMed ID: 27099313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV16 E6 induces chromosomal instability due to polar chromosomes caused by E6AP-dependent degradation of the mitotic kinesin CENP-E.
    Cosper PF; Hrycyniak LCF; Paracha M; Lee DL; Wan J; Jones K; Bice SA; Nickel K; Mallick S; Taylor AM; Kimple RJ; Lambert PF; Weaver BA
    Proc Natl Acad Sci U S A; 2023 Apr; 120(14):e2216700120. PubMed ID: 36989302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.